CN100443470C - 一种依巴斯汀的制备方法 - Google Patents
一种依巴斯汀的制备方法 Download PDFInfo
- Publication number
- CN100443470C CN100443470C CNB2006100526188A CN200610052618A CN100443470C CN 100443470 C CN100443470 C CN 100443470C CN B2006100526188 A CNB2006100526188 A CN B2006100526188A CN 200610052618 A CN200610052618 A CN 200610052618A CN 100443470 C CN100443470 C CN 100443470C
- Authority
- CN
- China
- Prior art keywords
- ebastine
- reaction
- add
- phenyl
- condensation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- MJJALKDDGIKVBE-UHFFFAOYSA-N ebastine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(=O)CCCN1CCC(OC(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 MJJALKDDGIKVBE-UHFFFAOYSA-N 0.000 title claims abstract description 26
- 229960001971 ebastine Drugs 0.000 title claims abstract description 26
- 238000006243 chemical reaction Methods 0.000 claims abstract description 31
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims abstract description 22
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 19
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000001273 butane Substances 0.000 claims abstract description 14
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims abstract description 13
- 238000005406 washing Methods 0.000 claims abstract description 13
- 238000009833 condensation Methods 0.000 claims abstract description 12
- 230000005494 condensation Effects 0.000 claims abstract description 12
- 239000012044 organic layer Substances 0.000 claims abstract description 10
- 238000002360 preparation method Methods 0.000 claims abstract description 9
- 238000010992 reflux Methods 0.000 claims abstract description 8
- 239000007787 solid Substances 0.000 claims abstract description 7
- 238000001914 filtration Methods 0.000 claims abstract description 6
- 238000003756 stirring Methods 0.000 claims abstract description 6
- YTZKOQUCBOVLHL-UHFFFAOYSA-N tert-butylbenzene Chemical compound CC(C)(C)C1=CC=CC=C1 YTZKOQUCBOVLHL-UHFFFAOYSA-N 0.000 claims abstract description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 6
- CDIIZULDSLKBKV-UHFFFAOYSA-N 4-chlorobutanoyl chloride Chemical compound ClCCCC(Cl)=O CDIIZULDSLKBKV-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000003999 initiator Substances 0.000 claims abstract description 5
- HDOWRFHMPULYOA-UHFFFAOYSA-N piperidin-4-ol Chemical compound OC1CCNCC1 HDOWRFHMPULYOA-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000000376 reactant Substances 0.000 claims abstract description 5
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 24
- -1 chloro ditane Chemical compound 0.000 claims description 22
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 19
- 239000003518 caustics Substances 0.000 claims description 10
- 238000005502 peroxidation Methods 0.000 claims description 10
- 238000001035 drying Methods 0.000 claims description 6
- ZTQSAGDEMFDKMZ-UHFFFAOYSA-N Butyraldehyde Chemical compound CCCC=O ZTQSAGDEMFDKMZ-UHFFFAOYSA-N 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 5
- 238000006482 condensation reaction Methods 0.000 claims description 5
- 239000012530 fluid Substances 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 4
- 239000012295 chemical reaction liquid Substances 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- 235000017550 sodium carbonate Nutrition 0.000 claims description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 3
- QWXYZCJEXYQNEI-OSZHWHEXSA-N intermediate I Chemical compound COC(=O)[C@@]1(C=O)[C@H]2CC=[N+](C\C2=C\C)CCc2c1[nH]c1ccccc21 QWXYZCJEXYQNEI-OSZHWHEXSA-N 0.000 abstract 2
- RLKSQLJFGCDUOX-UHFFFAOYSA-N 1-(4-tert-butylphenyl)-4-chlorobutan-1-one Chemical compound CC(C)(C)C1=CC=C(C(=O)CCCCl)C=C1 RLKSQLJFGCDUOX-UHFFFAOYSA-N 0.000 abstract 1
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 abstract 1
- ZDVDCDLBOLSVGM-UHFFFAOYSA-N [chloro(phenyl)methyl]benzene Chemical compound C=1C=CC=CC=1C(Cl)C1=CC=CC=C1 ZDVDCDLBOLSVGM-UHFFFAOYSA-N 0.000 abstract 1
- 229940043265 methyl isobutyl ketone Drugs 0.000 abstract 1
- 230000007935 neutral effect Effects 0.000 abstract 1
- FKGFBYXUGQXYKX-UHFFFAOYSA-N phenyl ethaneperoxoate Chemical compound CC(=O)OOC1=CC=CC=C1 FKGFBYXUGQXYKX-UHFFFAOYSA-N 0.000 abstract 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 229940088529 claritin Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 239000001530 fumaric acid Substances 0.000 description 2
- JCCNYMKQOSZNPW-UHFFFAOYSA-N loratadine Chemical compound C1CN(C(=O)OCC)CCC1=C1C2=NC=CC=C2CCC2=CC(Cl)=CC=C21 JCCNYMKQOSZNPW-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- DPDMMXDBJGCCQC-UHFFFAOYSA-N [Na].[Cl] Chemical compound [Na].[Cl] DPDMMXDBJGCCQC-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
Landscapes
- Hydrogenated Pyridines (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100526188A CN100443470C (zh) | 2006-07-21 | 2006-07-21 | 一种依巴斯汀的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100526188A CN100443470C (zh) | 2006-07-21 | 2006-07-21 | 一种依巴斯汀的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1887866A CN1887866A (zh) | 2007-01-03 |
CN100443470C true CN100443470C (zh) | 2008-12-17 |
Family
ID=37577148
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2006100526188A Active CN100443470C (zh) | 2006-07-21 | 2006-07-21 | 一种依巴斯汀的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100443470C (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2371817A1 (en) * | 2010-04-01 | 2011-10-05 | Arevipharma GmbH | Process for the preparation of 1-[4-(1,1-dimethylethyl)phenyl]-4-[4-(diphenylmethoxy)-1-piperidinyl]-1-butanone and acid addition salts thereof |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114671802B (zh) * | 2022-04-14 | 2024-05-17 | 江苏联环药业股份有限公司 | 一种高纯度依巴斯汀的制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4254129A (en) * | 1979-04-10 | 1981-03-03 | Richardson-Merrell Inc. | Piperidine derivatives |
US4550116A (en) * | 1983-08-05 | 1985-10-29 | Fordonal, S.A. | Piperidine derivatives |
US6448406B1 (en) * | 1995-12-21 | 2002-09-10 | Albany Molecular Research, Inc. | Process for production of piperidine derivatives |
CN1603291A (zh) * | 1993-06-25 | 2005-04-06 | 默里尔药物公司 | 用于制备抗组胺哌啶衍生物的新中间体 |
-
2006
- 2006-07-21 CN CNB2006100526188A patent/CN100443470C/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4254129A (en) * | 1979-04-10 | 1981-03-03 | Richardson-Merrell Inc. | Piperidine derivatives |
US4550116A (en) * | 1983-08-05 | 1985-10-29 | Fordonal, S.A. | Piperidine derivatives |
CN1603291A (zh) * | 1993-06-25 | 2005-04-06 | 默里尔药物公司 | 用于制备抗组胺哌啶衍生物的新中间体 |
US6448406B1 (en) * | 1995-12-21 | 2002-09-10 | Albany Molecular Research, Inc. | Process for production of piperidine derivatives |
Non-Patent Citations (4)
Title |
---|
依巴斯汀的合成. 张爱华,沈义鹏.江苏药学与临床研究,第13卷第6期. 2005 |
依巴斯汀的合成. 张爱华,沈义鹏.江苏药学与临床研究,第13卷第6期. 2005 * |
依巴斯汀的合成工艺改进. 孙平华,唐文生,张虎山,孙铁民.中国医药工业杂志,第35卷第6期. 2004 |
依巴斯汀的合成工艺改进. 孙平华,唐文生,张虎山,孙铁民.中国医药工业杂志,第35卷第6期. 2004 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2371817A1 (en) * | 2010-04-01 | 2011-10-05 | Arevipharma GmbH | Process for the preparation of 1-[4-(1,1-dimethylethyl)phenyl]-4-[4-(diphenylmethoxy)-1-piperidinyl]-1-butanone and acid addition salts thereof |
WO2011121099A3 (en) * | 2010-04-01 | 2012-03-08 | Arevipharma Gmbh | Process for the preparation of 1-[4-(1,1-dimethylethyl)phenyl]-4-[4-(diphenylmethoxy)-1-piperidinyl]-1-butanone and acid addition salts thereof |
Also Published As
Publication number | Publication date |
---|---|
CN1887866A (zh) | 2007-01-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104558031B (zh) | 一种苯基双(2,4,6-三甲基苯甲酰基)氧化膦的制备方法 | |
CN100443470C (zh) | 一种依巴斯汀的制备方法 | |
Periasamy et al. | Synthesis of Amines by Reduction of Imines with the MCl2/NaBH4 (M= Co, Ni) System | |
JP5013366B2 (ja) | ビス(ターピリジン)化合物の合成方法 | |
CN107266344A (zh) | 一种过氧化环己酮的制备方法 | |
CN104130194A (zh) | 一种5-氨基苯并咪唑酮的合成方法 | |
JP4574522B2 (ja) | 多孔質シリカ誘導体 | |
CN101168531A (zh) | 一种橡胶促进剂dz的合成方法 | |
CN107501059B (zh) | 一种绿色环保的4-(4’-烷基环己基)环己酮的合成方法 | |
CN115433114A (zh) | 一种3-羟基四氢吡咯类化合物的合成方法 | |
Firouzabadi et al. | MODIFIED BOROHYDRIDE AGENTS, BIS (TRIPHENYLPHOSPHINE)(TETRA-HYDROBORATO) ZINC COMPLEX [Zn (BH4 2 (PPh3) 2] AND (TRIPHENYLPHOSPHINE)(TETRAHYDROBORATO) ZINC COMPLEX [Zn (BH4) 2 (PPh3)]. NEW LIGAND METAL BOROHYDRIDES AS STABLE, EFFICIENT, AND VERSATILE REDUCING AGENTS | |
CN106748953A (zh) | 一种二氢吡咯‑3‑甲酸酯类化合物的合成方法 | |
CN105111128B (zh) | 一种n‑羟基邻苯二甲酰亚胺的制备方法 | |
CN109608491B (zh) | 一种二乙基次膦酸盐的制备方法 | |
Park et al. | Facile and selective aerobic oxidation of arylalkanes to aryl ketones using cesium carbonate | |
Jian et al. | Nitroacenaphthene as a New Photocatalyst for the Synthesis of Sulfonyl Amidines | |
CN1239715A (zh) | N-羟基邻苯二甲酰亚胺的合成方法 | |
JP2007223933A (ja) | シクロアルカノール及びシクロアルカノンの製法 | |
CN101023059B (zh) | 制备稳定的硝基氧自由基的方法 | |
CN104072647B (zh) | 一类含卤聚合物的制备及其作为氧化反应催化剂催化氧化醇到醛酮的方法 | |
Farsi et al. | CRS | |
CN107663184A (zh) | 一种N‑Boc‑4‑羟基哌啶的合成方法 | |
CN101379031A (zh) | 制备稳定的硝酰自由基的改进方法 | |
CN113511977B (zh) | 一种采用光催化多组分Petasis反应制备α-分支仲胺类化合物的方法 | |
KR100653507B1 (ko) | 농약 중간체로 유용한 벤질알콜 유도체의 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Hangzhou Aoyi Baoling Pharmaceutical Co., Ltd. Assignor: Hangzhou Baoling Co., Ltd. Contract fulfillment period: 2008.8.6 to 2026.7.21 Contract record no.: 2008330002022 Denomination of invention: Prepn of ebastine Granted publication date: 20081217 License type: Exclusive license Record date: 20081114 |
|
LIC | Patent licence contract for exploitation submitted for record |
Free format text: EXCLUSIVE LICENSE; TIME LIMIT OF IMPLEMENTING CONTACT: 2008.8.6 TO 2026.7.21; CHANGE OF CONTRACT Name of requester: HANGZHOU AOYI BAOLING PHARMACEUTICAL CO., LTD. Effective date: 20081114 |
|
C56 | Change in the name or address of the patentee |
Owner name: HANGZHOU BAOLING GROUP CO.,LTD. Free format text: FORMER NAME: HANGZHOU BAO LING CO., LTD. |
|
CP03 | Change of name, title or address |
Address after: Hangzhou City, Zhejiang Province, Gongshu District mid Baolinglu No. 5 Patentee after: Hangzhou Pollen Group Co.,Ltd. Address before: Hangzhou City, Zhejiang Province, Gongshu District mid Baolinglu No. 5 Patentee before: Hangzhou Baoling Co., Ltd. |
|
EC01 | Cancellation of recordation of patent licensing contract |
Assignee: Hangzhou Aoyi Baoling Pharmaceutical Co., Ltd. Assignor: Hangzhou Baoling Co., Ltd. Contract record no.: 2008330002022 Date of cancellation: 20160525 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160621 Address after: 310000 No. 23, No. 668, Hangzhou economic and Technological Development Zone, Hangzhou, Zhejiang Patentee after: Hangzhou Aoyi Baoling Pharmaceutical Co., Ltd. Address before: Hangzhou City, Zhejiang province 310022 Gongshu District mid Baolinglu No. 5 Patentee before: Hangzhou Pollen Group Co.,Ltd. |
|
CP03 | Change of name, title or address |
Address after: 310018 no.668, No.23 street, Hangzhou Economic and Technological Development Zone, Hangzhou, Zhejiang Province Patentee after: Hangzhou Qianyuan Baoling Pharmaceutical Co., Ltd Address before: 310000 No. 23, No. 668, Hangzhou economic and Technological Development Zone, Hangzhou, Zhejiang Patentee before: HANGZHOU AOYIPOLLEN PHARMACEUTICAL Co.,Ltd. |
|
CP03 | Change of name, title or address |